Concepedia

Thomas H. Vanderford

TH

Statistics

Publications

49

Citations

4.7K

H-Index

32

Active since

2003

Affiliations

Emory University(Current)

University of Pennsylvania

Children's Healthcare of Atlanta

University of North Carolina at Chapel Hill

Frederick National Laboratory for Cancer Research

Thomas H. Vanderford is an author at Emory University specializing in immunology, life sciences, and infectious diseases.

ORCID

Publications per year

2003–2023

49

Publications

49

Enhancing SIV-specific immunity in vivo by PD-1 blockade

Vijayakumar Velu, Kehmia Titanji, Baogong Zhu et al. · Nature · 2008 · 760 citations · Full text

, , +14

Global genomic analysis reveals rapid control of a robust innate response in SIV-infected sooty mangabeys

Steven E. Bosinger, Qingsheng Li, Shari N. Gordon et al. · Journal of Clinical Investigation · 2009 · 401 citations · Full text

, , +17

Divergent TLR7 and TLR9 signaling and type I interferon production distinguish pathogenic and nonpathogenic AIDS virus infections

Judith N. Mandl, Ashley P. Barry, Thomas H. Vanderford et al. · Nature Medicine · 2008 · 371 citations

, , +17

Systemic HIV and SIV latency reversal via non-canonical NF-κB signalling in vivo

Christopher C. Nixon, Maud Mavigner, Gavin C. Sampey et al. · Nature · 2020 · 319 citations · Full text

, , +16

Immune activation alters cellular and humoral responses to yellow fever 17D vaccine

Enoch Muyanja, Aloysius Ssemaganda, Pearline Ngauv et al. · Journal of Clinical Investigation · 2014 · 223 citations · Full text

, , +14

1–5 of 49